The daily business briefing: April 22, 2021

Pfizer identifies fake coronavirus vaccine vials in Mexico and Poland, Biden pledges to halve emissions as climate summit starts, and more

A Pfizer vaccine bottle
(Image credit: Getty Images)

1. Pfizer identifies fake coronavirus vaccine doses in Mexico, Poland

Pfizer has confirmed the first cases of counterfeit versions of its coronavirus vaccine, The Wall Street Journal reported Wednesday. The fake doses of the vaccine Pfizer developed with BioNTech were found in Mexico and Poland. Pfizer tested the vials after authorities seized them in separate investigations. About 80 people paid roughly $1,000 per dose for the phony vaccine at a Mexican clinic. The patients did not appear to have been harmed. "Everybody on the planet needs it. Many are desperate for it," said Lev Kubiak, Pfizer's world head of security. "We have a very limited supply, a supply that will increase as we ramp up and other companies enter the vaccine space. In the interim, there is a perfect opportunity for criminals."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.